A San Diego federal judge on Tuesday cleared a lawsuit against a La Jolla clinic purporting to offer stem cell treatments for various diseases to move toward trial on fraud and misrepresentation claims.
Judge Antony J. Battaglia dismissed several claims brought by three former patients at the clinic, including an allegation that Stemgenex has misled patients because it has produced no evidence that its treatments have any scientific basis. He said it’s unclear that the plaintiffs would be able to show that Stemgenex’s representations about the effectiveness of its treatments are “actually false or misleading” because they haven’t shown that the clinic’s claims have “actually been disproved.”
But he allowed the case to proceed on grounds that Stemgenex misrepresented customer satisfaction statistics on its website. The clinic claimed 100% patient satisfaction, even after the plaintiffs themselves complained that they hadn’t seen any improvement in their medical conditions.
By Anna Louie Sussman, The New York Times | 04.08.2025
Aggregated News
Before fertility patients begin the long journey through hormone treatments, egg retrieval, fertilization and — hopefully, if everything goes well — a baby, there’s the paperwork. As a first order of business, would-be parents are typically presented with a form...
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Aggregated News
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
With genetic testing company 23andMe facing an increasingly uncertain future, California Attorney General Rob Bonta on Friday reminded customers they have the right to tell the firm to permanently delete their data.
The South San Francisco-based company has publicly...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.